| 查看: 266 | 回复: 2 | ||
| 当前主题已经存档。 | ||
huangli8200新虫 (小有名气)
|
[交流]
请教这条意见该怎么回答
|
|
|
In you conclusions, you state "Due to their relative low size at tens of nanometers, Fe3O4/PANI nanoparticles are capable of minimizing reticuloendothelial system (RES) (liver and spleen) uptake upon intravenous injection while having an increased affinity for molecular targets." Nanoparticles (30-50nm) in excess of the glomeri pore size in the kidney (3-5nm) will clear through the liver. Note: Ref 37 states "Enhanced uptake in liver is commonly observed with carbohydrate-modified nanoparticle preparations because of the efficient uptake mechanism into cells of the reticuloendothelial system and the large blood volume and high perfusion of the liver. 谢谢各位虫虫，我该怎么回复这条意见？ |
回复此楼
huangli8200
新虫 (小有名气)
- 应助: 0 (幼儿园)
- 金币: 12
- 帖子: 77
- 在线: 13.2小时
- 虫号: 678369
- 注册: 2008-12-20
- 专业: medical imaging
2楼2010-03-07 23:37:14
huangli8200
新虫 (小有名气)
- 应助: 0 (幼儿园)
- 金币: 12
- 帖子: 77
- 在线: 13.2小时
- 虫号: 678369
- 注册: 2008-12-20
- 专业: medical imaging
3楼2010-03-08 11:04:09